K. ULUCAN Et Al. , "CYP2C19 genotype is important for dosage mpnitoring in patients under major depression treatment," Europaen Society of Human Genetics , Turkey, 2016
ULUCAN, K. Et Al. 2016. CYP2C19 genotype is important for dosage mpnitoring in patients under major depression treatment. Europaen Society of Human Genetics , (Turkey).
ULUCAN, K., sercan, C., KARAHAN, M., Yılancıoglu, K., ÜNÜBOL, H., KONUK, M., ... TARHAN, K. N.(2016). CYP2C19 genotype is important for dosage mpnitoring in patients under major depression treatment . Europaen Society of Human Genetics, Turkey
ULUCAN, KORKUT Et Al. "CYP2C19 genotype is important for dosage mpnitoring in patients under major depression treatment," Europaen Society of Human Genetics, Turkey, 2016
ULUCAN, KORKUT Et Al. "CYP2C19 genotype is important for dosage mpnitoring in patients under major depression treatment." Europaen Society of Human Genetics , Turkey, 2016
ULUCAN, K. Et Al. (2016) . "CYP2C19 genotype is important for dosage mpnitoring in patients under major depression treatment." Europaen Society of Human Genetics , Turkey.
@conferencepaper{conferencepaper, author={KORKUT ULUCAN Et Al. }, title={CYP2C19 genotype is important for dosage mpnitoring in patients under major depression treatment}, congress name={Europaen Society of Human Genetics}, city={}, country={Turkey}, year={2016}}